Today, Congresswoman Jennifer Wexton announced the introduction of a new bill which aims to fund research into environmental causes...see more of neurodegenerative disease. Wexton, a Democrat from Virginia, has been diagnosed with Progressive Supranuclear Palsy, a form of atypical parkinsonism, which has significantly impacted her movement, gait, and speech. As a member of Congress, she has […]

Read More

The National Plan to End Parkinson’s Act Has Been Signed into Law Today we celebratethe President’s signing of the...see more National Plan to End Parkinson’s Act, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson’s disease (PD) and ensuring quality care for those impacted by this chronic and progressive neurologic disease. […]

Read More

Congratulations to our 2020 APDA Research Grant Awardee Dr. Karen Jaunarajs for her work on understanding levodopa induced dyskinesias....see more Her study was recently published in Journal of Neuroscience. Dr. Jaunarajs works closely with Dr. David Standaert, Chairman of APDA’s Scientific Advisory Board, and the Chairman of University of Alabama at Birmingham’s Department of Neurology, which […]

Read More

In a recently published study, Dr. Gary Ho, a recipient of APDA’s most prestigious George C. Cotzias grant, studied...see more the role of alpha-synuclein in the formation and recycling of synaptic vesicles, the system that allows nerves to talk to each other. Abnormally aggregated alpha-synuclein is a main component of the Lewy body which is the […]

Read More

Parkinson’s pioneer and friend Dr. Mahlon DeLong was a pioneer in the Parkinson’s disease (PD) field and a dear...see more friend and longtime partner of the American Parkinson Disease Association (APDA). He sadly passed away on May 17, 2024. In tribute to Dr. DeLong, we reflect on the remarkable life and career of a man who […]

Read More

Breaking news! This week, the Senate passed the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s...see more Act! Now that the bill has passed through both houses of Congress, it heads to the President’s desk where it will be signed into law!  Here is some history about the National Plan: In 2022, the […]

Read More

The Glucagon-like peptide-1 (GLP-1) agonist lixisenatide and its potential role in treating PD. GLP-1 agonists are molecules that are...see more approved for use to treat type 2 diabetes (you may be familiar with brand names like Ozempic and Weygovy). They act by mimicking human gut hormones or incretins to stimulate the release of insulin. Receptors for […]

Read More

Skin Biopsy Update: The latest news re: efficacy and usefulness in Parkinson’s disease diagnosis, now and in the future ...see more A newly published study assessed the ability of a skin biopsy to diagnose Parkinson’s disease (PD) and related disorders and demonstrated that it was very accurate in distinguishing between those who had the disorders and those […]

Read More

Freezing of gait (FOG) is an abnormal gait pattern that can accompany Parkinson’s disease (PD) as well as other parkinsonian...see more disorders in which there are sudden, short, and temporary episodes of an inability to move the feet forward despite the intention to walk. These episodes can significantly  interfere in daily life and can result in falls. Treatments […]

Read More

Gait impairment can be a significant challenge as Parkinson’s disease (PD) advances, with balance problems, frequent falls, and freezing...see more of gait impeding quality of life. Often these challenges do not respond to increased amounts of PD medication or deep brain stimulation (DBS). In recent years, electrical stimulation of the spinal cord has been a research […]

Read More